Preparation, characterization, and evaluation of a heparin-benzalkonium chloride-graphite oxide/polymethylvinyl siloxane nanocomposite.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22447679.
- Also identified by DOI 10.1002/jbm.a.34110.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A heparin (Hep)-benzalkonium chloride (C12)-graphite oxide (GO)/polymethylvinyl siloxane (PMVS) nancomposite was prepared via melting intercalation at different temperatures. Scanning electron microscopy images showed the Hep-C12-GO was well dispersed into PMVS processed at 100°C. Mechanical properties measurement demonstrated that the addition of Hep-C12-GO maintained its strength. XRD data indicated that Hep-C12-GO lost its layer structure completely. FTIR results suggested that Hep-C12-GO interacted with PMVS strongly. Antibacterial activity of resulting nanocomposite was evaluated using zone of inhibition and bacteria adhesion methods. The results demonstrated that Hep-C12-GO/PMVS had a good capability against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Antithrombogenic properties were assessed using platelet adhesion experiment and the results showed that Hep-C12-GO/PMVS was blood-compatible.
Medical subject headings
- Benzalkonium Compounds
- Coated Materials, Biocompatible
- Graphite
- Heparin
- Nanocomposites
- Polyvinyls
- Siloxanes